Novel FXR agonist nelumal A suppresses colitis and inflammation-related colorectal carcinogenesis
Abstract FXR is a member of the nuclear receptor superfamily and bile acids are endogenous ligands of FXR. FXR activation has recently been reported to inhibit intestinal inflammation and tumour development. This study aimed to investigate whether the novel FXR agonist nelumal A, the active compound...
Guardado en:
Autores principales: | Tsuneyuki Miyazaki, Yohei Shirakami, Taku Mizutani, Akinori Maruta, Takayasu Ideta, Masaya Kubota, Hiroyasu Sakai, Takashi Ibuka, Salvatore Genovese, Serena Fiorito, Vito Alessandro Taddeo, Francesco Epifano, Takuji Tanaka, Masahito Shimizu |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/7ce700ce2ce149d58144ddadc34ce01f |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Inhibitory effects of a selective prostaglandin E2 receptor antagonist RQ-15986 on inflammation-related colon tumorigenesis in APC-mutant rats.
por: Yohei Shirakami, et al.
Publicado: (2021) -
Discovery, optimization, and evaluation of non-bile acid FXR/TGR5 dual agonists
por: Sachiho Miyata, et al.
Publicado: (2021) -
SUMOylation inhibitors synergize with FXR agonists in combating liver fibrosis
por: Jiyu Zhou, et al.
Publicado: (2020) - Carcinogenesis
-
Journal of carcinogenesis
Publicado: (2002)